“Flimsy Evidence” for Esketamine as Depression Treatment

9
A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

New Study Casts Doubt on Efficacy of Ketamine for Depression

10
A new study, published this month in the Journal of Affective Disorders, investigated the effectiveness of weekly intravenous ketamine injections as a treatment for...

Despite “Flurry of Interest,” Ketamine Remains Unproven For Depression

22
In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

Rise in Psychiatric Prescriptions With NOS Diagnosis

11
A “not otherwise specified” (NOS) diagnosis is often used when an individual may have some symptoms related to a psychiatric diagnosis but does not meet enough criteria to warrant a particular diagnosis. A new study, published online ahead of print in Psychiatric Services, reveals that the proportion of mental health visits resulting in such NOS diagnoses rose to nearly fifty percent, and that these diagnoses do not result in more conservative psychiatric drug prescriptions.

Doctors Tortured Patients at Ontario Mental-Health Centre

5
From The Globe and Mail: A judge has recently ruled that patients at a mental health facility in Ontario were tortured by doctors over a...

Can Psychedelics Help End Addictions with One Dose?

2
Q13 Fox News discusses recent research giving psychedelics to people struggling with alcohol or cigarettes. David Nutt, an Imperial College London neuro-psychopharmacologist "thinks psilocybin...

Ketamine for Harmful Drinking: A Look at the Data

11
New research contends that ketamine can reduce problematic alcohol use but does the data support the claims?

Researchers Find Inadequate Reporting of the Dangers of Ketamine Treatment for Depression

6
Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

British Government Plans to Illegalize All Unapproved Psychoactive Substances

0
A Kings College London psychiatrist worries what broad new British restrictions on psychoactive substances could mean for psychedelic research.

“Trust” In Therapeutic Relationship Key to Moderating Psychedelic Risks

2
-Psychiatry Advisor reports on psychiatrist James Rucker's campaign for more research into the therapeutic potentials of psychedelic drugs, and on critics who point to the risks.

Researchers Describe “Mind-blowing” Findings With Psychedelics

3
-Michael Pollan visits the resurgence of interest in the psychotherapeutic properties of psychedelic drugs in an essay in The New Yorker.

“Can psychedelic trips cure PTSD and other maladies?”

1
The Washington Post explores some of the history of research into the therapeutic potentials of even just one session with a psychedelic drug, and...

New Hope for Depression

3
In this piece for TIME, Mandy Oaklander provides a comprehensive review of the current status of and potential future directions for the depression treatment industry. The...

Dissolving the Ego: Transcendence and Ecstasy

0
From Aeon: Experiencing ecstasy and transcendence has long been pathologized and marginalized by Western culture and the psychiatric model of "mental illness." However, ecstatic experiences, including...

What Are “Hard” and “Soft” Drugs?

0
From Neuroskeptic: A new paper examines the often arbitrary distinction between "hard" and "soft" drugs, recommending that scientists avoid using these classifications in research publications. Article →­

New Study Investigates Cannabidiol (CBD) for Psychosis

21
A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

British Psychiatrists Advocate Psychedelics for Depression

15
The journal Therapeutic Advances in Psychopharmacology has published a review of what is known about psychedelic drugs' biochemical effects in the human brain, their...

The Important Drugs Debate Question That Nobody’s Asking

0
In this piece for Vice, Max Daly explores the impact of societal attitudes toward drug use and drug users on the drug policy debate over prohibition...

‘Ego-Dissolving’ Psychedelic Drugs Could Improve Mental Health

0
From Medical Xpress: Researchers have proposed that psychedelic drugs such as LSD and magic mushrooms may help some people with anxiety, depression, and addiction by dissolving...

“Warning Over Ketamine Use for Depression”

0
The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”

“FDA Agrees to New Trials for Ecstasy as Relief for PTSD Patients”

0
Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. “If they can keep...

“Healing with MDMA-assisted Psychotherapy” and Other Psychedelic Stories

4
The Multi-Disciplinary Association for Psychedelic Studies' Winter 2014 Bulletin is freely available. Among other articles, the issue includes a personal story of a patient,...

Psychedelic Use Associated with Reductions in Suicidal Tendencies

36
People who have taken a psychedelic drug at least once have less suicidal thinking than the general population.

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

0
From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

The Psychedelic Renaissance is Here. Will it Last This Time?

4
From Massive: Increasing evidence suggests that psychedelics may revolutionize mental health care. In order for this "psychedelic renaissance" to last, scientists and citizens will need...